Dodge & Cox’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $280M | Sell |
4,622,820
-2,455,430
| -35% | -$143M | 0.15% | 96 |
|
|
2025
Q4 | $382M | Sell |
7,078,250
-345,570
| -5% | -$16.6M | 0.21% | 89 |
|
|
2025
Q3 | $335M | Sell |
7,423,820
-1,012,939
| -12% | -$47.3M | 0.18% | 94 |
|
|
2025
Q2 | $391M | Sell |
8,436,759
-4,593,803
| -35% | -$226M | 0.22% | 85 |
|
|
2025
Q1 | $795M | Sell |
13,030,562
-2,371,906
| -15% | -$138M | 0.45% | 68 |
|
|
2024
Q4 | $871M | Sell |
15,402,468
-225,275
| -1% | -$12.6M | 0.51% | 66 |
|
|
2024
Q3 | $809M | Sell |
15,627,743
-139,155
| -0.9% | -$6.53M | 0.46% | 69 |
|
|
2024
Q2 | $655M | Sell |
15,766,898
-500,143
| -3% | -$22.4M | 0.39% | 71 |
|
|
2024
Q1 | $882M | Buy |
16,267,041
+66,757
| +0.4% | +$3.4M | 0.51% | 64 |
|
|
2023
Q4 | $831M | Sell |
16,200,284
-32,824
| -0.2% | -$1.72M | 0.53% | 65 |
|
|
2023
Q3 | $942M | Sell |
16,233,108
-171,238
| -1% | -$10.5M | 0.63% | 56 |
|
|
2023
Q2 | $1.05B | Sell |
16,404,346
-64,836
| -0.4% | -$4.35M | 0.7% | 55 |
|
|
2023
Q1 | $1.14B | Sell |
16,469,182
-75,162
| -0.5% | -$5.3M | 0.78% | 52 |
|
|
2022
Q4 | $1.19B | Sell |
16,544,344
-231,218
| -1% | -$17.4M | 0.82% | 47 |
|
|
2022
Q3 | $1.19B | Sell |
16,775,562
-1,577,777
| -9% | -$114M | 0.9% | 43 |
|
|
2022
Q2 | $1.41B | Sell |
18,353,339
-8,650,020
| -32% | -$659M | 0.98% | 39 |
|
|
2022
Q1 | $1.97B | Sell |
27,003,359
-352,073
| -1% | -$23.6M | 1.2% | 34 |
|
|
2021
Q4 | $1.71B | Sell |
27,355,432
-1,161,925
| -4% | -$68.2M | 1.06% | 37 |
|
|
2021
Q3 | $1.69B | Buy |
28,517,357
+43,699
| +0.2% | +$2.88M | 1.1% | 35 |
|
|
2021
Q2 | $1.9B | Buy |
28,473,658
+1,048,325
| +4% | +$68.4M | 1.24% | 32 |
|
|
2021
Q1 | $1.73B | Buy |
27,425,333
+776,638
| +3% | +$48.3M | 1.24% | 30 |
|
|
2020
Q4 | $1.65B | Sell |
26,648,695
-551,291
| -2% | -$33.9M | 1.31% | 31 |
|
|
2020
Q3 | $1.64B | Sell |
27,199,986
-1,355,403
| -5% | -$81.6M | 1.5% | 25 |
|
|
2020
Q2 | $1.68B | Sell |
28,555,389
-7,721,685
| -21% | -$462M | 1.54% | 25 |
|
|
2020
Q1 | $2.02B | Sell |
36,277,074
-13,991,703
| -28% | -$855M | 2.19% | 16 |
|
|
2019
Q4 | $3.23B | Sell |
50,268,777
-183,900
| -0.4% | -$10.5M | 2.47% | 13 |
|
|
2019
Q3 | $2.56B | Buy |
50,452,677
+808,153
| +2% | +$38M | 2.11% | 16 |
|
|
2019
Q2 | $2.25B | Buy |
49,644,524
+6,497,108
| +15% | +$303M | 1.82% | 22 |
|
|
2019
Q1 | $2.06B | Buy |
43,147,416
+559,459
| +1% | +$27.9M | 1.69% | 23 |
|
|
2018
Q4 | $2.21B | Buy |
42,587,957
+9,618,771
| +29% | +$517M | 2.03% | 18 |
|
|
2018
Q3 | $2.05B | Buy |
32,969,186
+264,100
| +0.8% | +$15.7M | 1.57% | 26 |
|
|
2018
Q2 | $1.81B | Buy |
32,705,086
+4,887,475
| +18% | +$264M | 1.45% | 29 |
|
|
2018
Q1 | $1.76B | Sell |
27,817,611
-1,288,500
| -4% | -$82.9M | 1.42% | 30 |
|
|
2017
Q4 | $1.78B | Buy |
29,106,111
+51,150
| +0.2% | +$3.2M | 1.38% | 30 |
|
|
2017
Q3 | $1.85B | Sell |
29,054,961
-524,500
| -2% | -$30.6M | 1.49% | 30 |
|
|
2017
Q2 | $1.65B | Buy |
29,579,461
+459,271
| +2% | +$25M | 1.39% | 29 |
|
|
2017
Q1 | $1.58B | Buy |
29,120,190
+6,587,429
| +29% | +$361M | 1.35% | 28 |
|
|
2016
Q4 | $1.32B | Buy |
22,532,761
+22,460,803
| +31,214% | +$1.23B | 1.17% | 34 |
|
|
2016
Q3 | $3.88M | Sell |
71,958
-200
| -0.3% | -$12.8K | ﹤0.01% | 106 |
|
|
2016
Q2 | $5.31M | Sell |
72,158
-1,300
| -2% | -$91.9K | 0.01% | 100 |
|
|
2016
Q1 | $4.69M | Sell |
73,458
-4,000
| -5% | -$252K | ﹤0.01% | 102 |
|
|
2015
Q4 | $5.33M | Sell |
77,458
-2,470
| -3% | -$163K | 0.01% | 104 |
|
|
2015
Q3 | $4.73M | Sell |
79,928
-1,000
| -1% | -$63.4K | ﹤0.01% | 99 |
|
|
2015
Q2 | $5.38M | Sell |
80,928
-6,900
| -8% | -$455K | ﹤0.01% | 95 |
|
|
2015
Q1 | $5.67M | Sell |
87,828
-3,200
| -4% | -$200K | 0.01% | 98 |
|
|
2014
Q4 | $5.37M | Buy |
91,028
+600
| +0.7% | +$33.8K | 0.01% | 100 |
|
|
2014
Q3 | $4.63M | Buy |
90,428
+11,507
| +15% | +$575K | ﹤0.01% | 98 |
|
|
2014
Q2 | $3.83M | Sell |
78,921
-200
| -0.3% | -$9.86K | ﹤0.01% | 101 |
|
|
2014
Q1 | $4.11M | Sell |
79,121
-800
| -1% | -$42.6K | ﹤0.01% | 99 |
|
|
2013
Q4 | $4.25M | Sell |
79,921
-200
| -0.2% | -$10.2K | ﹤0.01% | 100 |
|
|
2013
Q3 | $3.71M | Hold |
80,121
| – | – | ﹤0.01% | 102 |
|
|
2013
Q2 | $3.58M | Buy |
+80,121
| New | +$3.48M | ﹤0.01% | 102 |
|
Other funds holding BMY
VCM
VPM
Dodge & Cox's BMY Position: Q1 2026 in Review
Dodge & Cox reduced its Bristol-Myers Squibb (BMY) stake by 35% in Q1 2026, selling an estimated $143M and leaving 4,622,820 shares worth $280M. The position accounts for 0.15% of the portfolio, ranked #96.
Dodge & Cox first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.23B in Q4 2019. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Dodge & Cox held 4,622,820 shares of Bristol-Myers Squibb worth $280M as of Q1 2026.
- Dodge & Cox sold 2,455,430 Bristol-Myers Squibb shares in Q1 2026, an estimated $143M.
- Bristol-Myers Squibb made up 0.15% of Dodge & Cox's portfolio in Q1 2026, its #96 holding.
- Dodge & Cox first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Dodge & Cox's Bristol-Myers Squibb position peaked at $3.23B in Q4 2019.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Dodge & Cox's 13F filing for Q1 2026, filed 14 May 2026.